Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
It is not appropriate during pregnancy or breastfeeding, in active cancer, or in patients with severely uncontrolled metabolic disease without specialist coordination
PMID: 27456173
Without writing a book and explaining every single trial in detail, Ill share the key takeaway points: Trials #1-4 demonstrated an excellent safety profile in which AOD-9604 was well-tolerated and safe, with next to no difference compared to a placebo Trial #5 saw patients taking the AOD-9604 peptide lose 2.8 kg on a dose of 1 mg, compared to the placebo group losing 0.8 kg over the same time period
Its evidence is preclinical, centred on metabolic and adipose models
The key elements to document include: Drug Information: Record the exact name of the drug or biologic administered, including both brand and generic names if applicable, the precise dosage and the corresponding HCPCS or J-code
Legal Disclaimer This product is intended strictly for laboratory research purposes only
